Literature DB >> 14633828

Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics.

Daad H Akbar, Abeer H Kawther.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14633828     DOI： 10.2337/diacare.26.12.3351-a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  22 in total

Review 1.  Nonalcoholic fatty liver disease and polycystic ovary syndrome.

Authors:  Evangeline Vassilatou
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

Authors:  Leon A Adams; Scott Harmsen; Jennifer L St Sauver; Phunchai Charatcharoenwitthaya; Felicity B Enders; Terry Therneau; Paul Angulo
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

3.  Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.

Authors:  Masahide Hamaguchi; Noriyuki Takeda; Takao Kojima; Akihiro Ohbora; Takahiro Kato; Hiroshi Sarui; Michiaki Fukui; Chisato Nagata; Jun Takeda
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

4.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Mitsuhito Koizumi; Yoshio Tokumoto; Teruhisa Ueda; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-08-31       Impact factor: 7.527

5.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  High-sensitivity C-reactive protein and liver enzymes in individuals with Metabolic Syndrome in Talca, Chile.

Authors:  E Leiva; V Mujica; I Palomo; R Orrego; L Guzmán; S Núñez; R Moore-Carrasco; G Icaza; N Díaz
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

7.  Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.

Authors:  Yongyuan Zhang; Tao Zhang; Chengqi Zhang; Fang Tang; Nvjuan Zhong; Hongkai Li; Xinhong Song; Haiyan Lin; Yanxun Liu; Fuzhong Xue
Journal:  BMJ Open       Date:  2015-09-22       Impact factor: 2.692

Review 8.  Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?

Authors:  Mohamed H Ahmed; Salma Barakat; Ahmed O Almobarak
Journal:  J Obes       Date:  2012-12-23

9.  Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus.

Authors:  Hai Jin Kim; Min Ho Cho; Jong Suk Park; Ji Sun Nam; Eun Seok Kang; Chul Woo Ahn; Bong Soo Cha; Eun Jig Lee; Sung Kil Lim; Kyung Rae Kim; Hyun Chul Lee; Kap Bum Huh
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

10.  Assessment of the relationship between non-alcoholic fatty liver disease and CAD using MSCT.

Authors:  Duran Efe; Fatih Aygün
Journal:  Arq Bras Cardiol       Date:  2013-11-22       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.